Curcumin: A natural product for diabetes and its complications

Current Topics in Medicinal Chemistry

Volumn 15, Issue 23, 2015, Pages 2445-2455

  Nabavi, Seyed Fazel ^a   Thiagarajan, Raman ^b   Rastrelli, Luca ^c   Daglia, Maria ^d   Sobarzo Sánchez, Eduardo ^e   Alinezhad, Heshmatollah ^f   Nabavi, Seyed Mohammad ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SASTRA UNIVERSITY   (India)

^c UNIVERSITY OF SALERNO   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^f UNIVERSITY OF MAZANDARAN   (Iran)

Author keywords

Curcuma longa L; Curcumin; Diabetes; Inflammation; Oxidative stress

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CURCUMIN; HEMOGLOBIN A1C; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN C FOS; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1; ANTIDIABETIC AGENT;

ANTIDIABETIC ACTIVITY; ARTICLE; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; GLUCOSE BLOOD LEVEL; GLYCATION; HUMAN; INFLAMMATION; NONHUMAN; OSTEOCLASTOGENESIS; OSTEOLYSIS; OXIDATIVE STRESS; PROTEIN EXPRESSION; BIOAVAILABILITY; CHEMICAL STRUCTURE; CHEMISTRY; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2;

BIOLOGICAL AVAILABILITY; CURCUMIN; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; MOLECULAR STRUCTURE;

EID: 84940910067     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026615666150619142519     Document Type: Article

References (169)

1. [1] American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes care, 2013, 36(Suppl 1), S67-S74.
2. [2] Forbes, J.M.; Cooper, M.E. Mechanisms of diabetic complications. Physiol. Rev., 2013, 93(1), 137-188.
3. [3] Calles-Escandon, J.; Cipolla, M. Diabetes and endothelial dysfunction: a clinical perspective. Endocr.Rev., 2001, 22(1), 36-52.
4. [4] Nabavi, S.; Habtemariam, S.; Daglia, M.; Shafighi, N.; Barber, A.; Nabavi, S. Anthocyanins as a potential therapy for diabetic retinopathy. Curr. Med. Chem., 2015, 22(1), 51-58.
5. [5] Yorek, M.A. In Studies in Diabetes; Springer: New York. 2014, pp 1-12.
6. [6] Bugger, H.; Abel, E.D. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia, 2014, 57(4), 660-671.
7. [7] Fried, L.F.; Emanuele, N.; Zhang, J.H.; Brophy, M.; Conner, T.A.; Duckworth, W.; Leehey, D.J.; McCullough, P.A.; O'Connor, T.; Palevsky, P.M. Combined angiotensin inhibition for the treatment of diabetic nephropathy. N. Engl. J. Med., 2013, 369(20), 1892-1903.
8. [8] Vlassara, H.; Cai, W.; Crandall, J.; Goldberg, T.; Oberstein, R.; Dardaine, V.; Peppa, M.; Rayfield, E.J. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc. Natl. Acad. Sci., 2002, 99(24), 15596-15601.
9. [9] Boulton, A.J.; Vileikyte, L.; Ragnarson-Tennvall, G.; Apelqvist, J. The global burden of diabetic foot disease. Lancet, 2005, 366(9498), 1719-1724.
10. [10] Gardner, D.G.; Shoback, D.M. Greenspan's basic & clinical endocrinology. McGraw-Hill Medical: New York, 2007.
11. [11] Eizirik, D.L.; Colli, M.L.; Ortis, F. The role of inflammation in insulitis and β-cell loss in type 1 diabetes. Nat. Rev. Endocrinol., 2009, 5(4), 219-226.
12. [12] Reinehr, T. Type 2 diabetes mellitus in children and adolescents. World J. Diabetes, 2013, 4(6), 270.
13. [13] American Diabetes Association. Standards of medical care in diabetes—2010. Diabetes care, 2010, 33(Suppl 1), S11-S61.
14. [14] Yau, J.W.; Rogers, S.L.; Kawasaki, R.; Lamoureux, E.L.; Kowalski, J.W.; Bek, T.; Chen, S.-J.; Dekker, J.M.; Fletcher, A.; Grauslund, J. Global prevalence and major risk factors of diabetic retinopathy. Diabetes care, 2012, 35(3):556-564.
15. [15] Wada, J.; Makino, H. Inflammation and the pathogenesis of diabetic nephropathy. Clin. Sci., 2013, 124(3), 139-152.
16. [16] Tesfaye, S.; Selvarajah, D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab. Res. Rev., 2012, 28(S1), 8-14.
17. [17] Miki, T.; Yuda, S.; Kouzu, H.; Miura, T. Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail. Rev., 2013, 18(2), 149-166.
18. [18] Xu, L.; Kanasaki, K.; Kitada, M.; Koya, D. Diabetic angiopathy and angiogenic defects. Fibrogenesis Tissue Repair., 2012, 5(1), 13-13.
19. [19] Rogers, L.C.; Frykberg, R.G.; Armstrong, D.G.; Boulton, A.J.; Edmonds, M.; Van, G.H.; Hartemann, A.; Game, F.; Jeffcoate, W.; Jirkovska, A. The Charcot foot in diabetes. Diabetes Care, 2011, 34(9), 2123-2129.
20. [20] Vinik, A.I.; Maser, R.E.; Mitchell, B.D.; Freeman, R. Diabetic autonomic neuropathy. Diabetes care, 2003, 26(5), 1553-1579.
21. [21] Beckman, J.A.; Creager, M.A.; Libby, P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA, 2002, 287(19), 2570-2581.
22. [22] Peripheral, I.O. Peripheral arterial disease in people with diabetes. Diabetes care, 2003, 26(12), 3333.
23. [23] Fetter, M. Diabetes and cerebrovascular disease. Clin. Res. Cardiol., 2006, 95, i59-62.
24. [24] Gress, T.W.; Nieto, F.J.; Shahar, E.; Wofford, M.R.; Brancati, F.L. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. N. Engl. J. Med., 2000, 342(13), 905-912.
25. [25] Moloney, F.; Yeow, T.-P.; Mullen, A.; Nolan, J.J.; Roche, H.M. Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. Am. J. Clin. Nutr., 2004, 80(4), 887-895.
26. [26] King, G.L. The role of inflammatory cytokines in diabetes and its complications. J. Periodontol., 2008, 79(8S), 1527-1534.
27. [27] Rolo, A.P.; Palmeira, C.M. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol. Appl. Pharmacol., 2006, 212(2), 167-178.
28. [28] Biondi-Zoccai, G.G.; Abbate, A.; Liuzzo, G.; Biasucci, L.M. Atherothrombosis, inflammation, and diabetes. J. Am. Coll. Cardiol., 2003, 41(7), 1071-1077.
29. [29] Nabavi, S.F.; Nabavi, S.M.; N Setzer, W.; Nabavi, S.A.; Nabavi, S.A.; Ebrahimzadeh, M.A. Antioxidant and antihemolytic activity of lipid-soluble bioactive substances in avocado fruits. Fruits, 2013, 68(03), 185-193.
30. [30] Nabavi, S.F.; M Dean, O.; Turner, A.; Sureda, A.; Daglia, M.; Nabavi, S.M. Oxidative stress and post-stroke depression: possible therapeutic role of polyphenols? Curr. Med. Chem., 2015, 22(3), 343-351.
31. [31] Sedeek, M.; Montezano, A.C.; Hebert, R.L.; Gray, S.P.; Di Marco, E.; Jha, J.C.; Cooper, M.E.; Jandeleit-Dahm, K.; Schiffrin, E.L.; Wilkinson-Berka, J.L. Oxidative stress, Nox isoforms and complications of diabetes—potential targets for novel therapies. J. Cardiovasc. Transl. Res., 2012, 5(4), 509-518.
32. [32] Goldfine, A.B.; Fonseca, V.; Shoelson, S.E. Therapeutic approaches to target inflammation in type 2 diabetes. Clin. Chem., 2011, 57(2), 162-167.
33. [33] Eyre, H.; Kahn, R.; Robertson, R.M.; Clark, N.G.; Doyle, C.; Gansler, T.; Glynn, T.; Hong, Y.; Smith, R.A.; Taubert, K. Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. CA Cancer J. Clin., 2004, 54(4), 190-207.
34. [34] Nabavi, S.M.; Nabavi, S.F.; Eslami, S.; Moghaddam, A.H. In vivo protective effects of quercetin against sodium fluoride-induced oxidative stress in the hepatic tissue. Food Chem., 2012, 132(2), 931-935.
35. [35] Nabavi, S.F.; Nabavi, S.M.; Habtemariam, S.; Moghaddam, A.H.; Sureda, A.; Jafari, M.; Latifi, A.M. Hepatoprotective effect of gallic acid isolated from Peltiphyllum peltatum against sodium fluoride- induced oxidative stress. Ind. Crops Prod., 2013, 44, 50-55.
36. [36] Nabavi, S.F.; Nabavi, S.M.; Mirzaei, M.; Moghaddam, A.H. Protective effect of quercetin against sodium fluoride induced oxidative stress in rat's heart. Food funct., 2012, 3(4), 437-441.
37. [37] Hokayem, M.; Blond, E.; Vidal, H.; Lambert, K.; Meugnier, E.; Feillet-Coudray, C.; Coudray, C.; Pesenti, S.; Luyton, C.; Lambert-Porcheron, S. Grape polyphenols prevent fructose-induced oxidative stress and insulin resistance in first-degree relatives of type 2 diabetic patients. Diabetes Care, 2013, 36(6), 1454-1461.
38. [38] Brasnyó, P.; Molnár, G.A.; Mohás, M.; Markó, L.; Laczy, B.; Cseh, J.; Mikolás, E.; Szijártó, I.A.; Mérei, A.; Halmai, R. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br. J. Nutr., 2011, 106(03), 383-389.
39. [39] Nabavi, S.F.; Nabavi, S.M.; Ebrahimzadeh, M.A.; Jafari, N.; Yazdanpanah, S. Biological activities of freshwater algae, Spirogyra singularis Nordstedt. J. Aquat. Food Prod. Technol., 2013, 22(1), 58-65.
40. [40] Ceriello, A.; Motz, E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler. Thromb. Vasc. Biol., 2004, 24(5), 816-823.
41. [41] Ceriello, A. New insights on oxidative stress and diabetic complications may lead to a “causal” antioxidant therapy. Diabetes Care, 2003, 26(5), 1589-1596.
42. [42] Nabavi, S.F.; Russo, G.L.; Daglia, M.; Nabavi, S.M. Role of quercetin as an alternative for obesity treatment: you are what you eat! Food Chem., 2015, 179, 305-310.
43. [43] Nabavi, S.F.; Nabavi, S.M.; Moghaddam, A.H., Naqinezhad, A., Bigdellou, R., Mohammadzadeh, S. Protective effects of Allium paradoxum against gentamicin-induced nephrotoxicity in mice. Food Funct., 2012, 3(1), 28-29.
44. [44] Nabavi, S.F.; Nabavi, S.M.; Ebrahimzadeh, M.A.; Eslami, B.; Jafari, N. In vitro antioxidant and antihemolytic activities of hydroalcoholic extracts of Allium scabriscapum Boiss. & Ky. aerial parts and bulbs. Int. J. Food Prop., 2013, 16(4), 713-722.
45. [45] Alinezhad, H.; Azimi, R.; Zare, M.; Ebrahimzadeh, M.A.; Eslami, S.; Nabavi, S.F.; Nabavi, S.M. Antioxidant and antihemolytic activities of ethanolic extract of flowers, leaves, and stems of Hyssopus officinalis L. Var. angustifolius. Int. J. Food Prop., 2013, 16(5), 1169-1178.
46. [46] Curti, V.; Capelli, E.; Boschi, F.; Nabavi, S.F.; Bongiorno, A.I.; Habtemariam, S.; Nabavi, S.M.; Daglia, M. Modulation of human miR-17–3p expression by methyl 3-O-methyl gallate as explanation of its in vivo protective activities. Mol. Nutr. Food Res., 2014, 58(9), 1776-1784.
47. [47] Srinivasan, K. Plant foods in the management of diabetes mellitus: spices as beneficial antidiabetic food adjuncts. Int. J. Food Sci. Nutr., 2005, 56(6), 399-414.
48. [48] Watal, G.; Dhar, P.; Srivastava, S.K.; Sharma, B. Herbal Medicine as an Alternative medicine for treating diabetes: the global burden. Evid. Based Complement. Alternat. Med., 2014, 2014.
49. [49] Li, G.Q.; Kam, A.; Wong, K.H.; Zhou, X.; Omar, E.A.; Alqahtani, A.; Li, K.M.; Razmovski-Naumovski, V.; Chan, K. In Diabetes; Springer: New York, 2013, pp 396-413.
50. [50] Nabavi, S.M.; Marchese, A.; Izadi, M.; Curti, V.; Daglia, M.; Nabavi, S.F. Plants belonging to the genus Thymus as antibacterial agents: From farm to pharmacy. Food chem., 2015, 173, 339-347.
51. [51] Nabavi, S.F.; Daglia, M.; Moghaddam, A.H.; Habtemariam, S.; Nabavi, S.M. Curcumin and liver disease: from chemistry to medicine. Compr. Rev. Food Sci. Food Saf., 2014, 13(1), 62-77.
52. [52] Kuo, M.L.; Huang, T.S.; Lin, J.K. Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim. Biophys. Acta -Mol. Basis Dis., 1996, 1317(2), 95-100.
53. [53] Chen, D.Y.; Shien, J.H.; Tiley, L.; Chiou, S.S.; Wang, S.Y.; Chang, T.J.; Lee, Y.J.; Chan, K.W.; Hsu, W.L. Curcumin inhibits influenza virus infection and haemagglutination activity. Food Chem., 2010, 119(4), 1346-1351.
54. [54] Panahi, Y.; Sahebkar, A.; Amiri, M.; Davoudi, S.M.; Beiraghdar, F.; Hoseininejad, S.L.; Kolivand, M. Improvement of sulphur mustard- induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebocontrolled trial. Br. J. Nutr., 2012, 108(07), 1272-1279.
55. [55] Panahi, Y.; Sahebkar, A.; Parvin, S.; Saadat, A. A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications. Ann. Clin. Biochem., 2012, 49(6), 580-588.
56. [56] Panahi, Y.; Rahimnia, A.R.; Sharafi, M.; Alishiri, G.; Saburi, A.; Sahebkar, A. Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial. Phytother. Res., 2014, 28(11), 1625-1631.
57. [57] Tilak, J.C.; Banerjee, M.; Mohan, H.; Devasagayam, T. Antioxidant availability of turmeric in relation to its medicinal and culinary uses. Phytother. Res., 2004, 18(10), 798-804.
58. [58] Meng, B.; Li, J.; Cao, H. Antioxidant and antiinflammatory activities of curcumin on diabetes mellitus and its complications. Curr. Pharm. Des., 2013, 19(11), 2101-2113.
59. [59] Chiu, J.; Khan, Z.A.; Farhangkhoee, H.; Chakrabarti, S. Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-κB. Nutrition, 2009, 25(9), 964-972.
60. [60] Kowluru, R.A.; Kanwar, M. Effects of curcumin on retinal oxidative stress and inflammation in diabetes. Nutr. Metab., 2007, 4, 8.
61. [61] Rungseesantivanon, S.; Thenchaisri, N.; Ruangvejvorachai, P.; Patumraj, S. Curcumin supplementation could improve diabetesinduced endothelial dysfunction associated with decreased vascular superoxide production and PKC inhibition. BMC Complement. Altern. Med., 2010, 10(1), 57.
62. [62] Chuengsamarn, S.; Rattanamongkolgul, S.; Luechapudiporn, R.; Phisalaphong, C.; Jirawatnotai, S. Curcumin extract for prevention of type 2 diabetes. Diabetes Care, 2012, 35(11), 2121-2127.
63. [63] Vyas, A.; Dandawate, P.; Padhye, S.; Ahmad, A.; Sarkar, F. Perspectives on new synthetic curcumin analogs and their potential anticancer properties. Curr. Pharm. Des., 2013, 19(11), 2047-2069.
64. [64] Aggarwal, B.B.; Deb, L.; Prasad, S. Curcumin differs from tetrahydrocurcumin for molecular targets, signaling pathways and cellular responses. Molecules, 2014, 20(1), 185-205.
65. [65] Farombi, E.O.; Shrotriya, S.; Na, H.K.; Kim, S.H.; Surh, Y.J. Curcumin attenuates dimethylnitrosamine-induced liver injury in rats through Nrf2-mediated induction of heme oxygenase-1. Food Chem. Toxicol., 2008, 46(4), 1279-1287.
66. [66] Anand, P.; Sung, B.; Kunnumakkara, A.B.; Rajasekharan, K.N.; Aggarwal, B.B. Suppression of pro-inflammatory and proliferative pathways by diferuloylmethane (curcumin) and its analogues dibenzoylmethane, dibenzoylpropane, and dibenzylideneacetone: role of Michael acceptors and Michael donors. Biochem. Pharmacol., 2011, 82(12), 1901-1909.
67. [67] Anand, P.; Thomas, S.G.; Kunnumakkara, A.B.; Sundaram, C.; Harikumar, K.B.; Sung, B.; Tharakan, S.T.; Misra, K.; Priyadarsini, I.K.; Rajasekharan, K.N. Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem. Pharmacol., 2008, 76(11), 1590-1611.
68. [68] Hazra, M.K.; Roy, S.; Bagchi, B. Hydrophobic hydration driven self-assembly of Curcumin in water: Similarities to nucleation and growth under large metastability, and an analysis of water dynamics at heterogeneous surfaces. J. Chem. Physics., 2014, 141(18), 18C501.
69. [69] Kolev, T.M.; Velcheva, E.A.; Stamboliyska, B.A.; Spiteller, M. DFT and experimental studies of the structure and vibrational spectra of curcumin. Int. J. Quantum. Chem., 2005, 102(6), 1069-1079.
70. [70] Peng, Y.M.; Zheng, J.B.; Zhou, Y.B.; Li, J. Characterization of a novel curcumin analog P1 as potent inhibitor of the NF-κB signaling pathway with distinct mechanisms. Acta Pharmacol. Sin., 2013, 34(7), 939-950.
71. [71] Moos, P.J.; Edes, K.; Mullally, J.E.; Fitzpatrick, F.A. Curcumin impairs tumor suppressor p53 function in colon cancer cells. Carcinogenesis, 2004, 25(9), 1611-1617.
72. [72] Simoni, D.; Rizzi, M.; Rondanin, R.; Baruchello, R.; Marchetti, P.; Invidiata, F.P.; Labbozzetta, M.; Poma, P.; Carina, V.; Notarbartolo, M. Antitumor effects of curcumin and structurally β-diketone modified analogs on multidrug resistant cancer cells. Bioorg. Med. Chem. Lett., 2008, 18(2), 845-849.
73. [73] Awasthi, S.; Pandya, U.; Singhal, S.S.; Lin, J.T.; Thiviyanathan, V.; Seifert, W.E.; Awasthi, Y.C.; Ansari, G. Curcumin–glutathione interactions and the role of human glutathione S-transferase P1-1. Chem. Biol. Interact., 2000, 128(1), 19-38.
74. [74] El Khoury, E.; Abiad, M.; Kassaify, Z.G.; Patra, D. Green synthesis of curcumin conjugated nanosilver for the applications in nucleic acid sensing and anti-bacterial activity. Colloids Surf., B. 2015, 127, 274-280.
75. [75] Pang, S.C.; Tay, S.H.; Chin, S.F. Facile synthesis of curcuminloaded starch-maleate nanoparticles. J. Nanomater., 2014, 824025/1-824025/8, 1-7.
76. [76] Bhaskar Rao, A.; Prasad, E.; Deepthi, S.S.; Ansari, I.A. Synthesis and biological evaluation of Glucosyl Curcuminoids. Arch. Pharm., 2014, 347(11), 834-839.
77. [77] Sharma, R.; Jadav, S.S.; Yasmin, S.; Bhatia, S.; Khalilullah, H.; Ahsan, M.J. Simple, efficient, and improved synthesis of Biginellitype compounds of curcumin as anticancer agents. Med. Chem. Res., 2015, 24(2), 636-644.
78. [78] Campos, C.A.; Gianino, J.B.; Bailey, B.J.; Baluyut, M.E.; Wiek, C.; Hanenberg, H.; Shannon, H.E.; Pollok, K.E.; Ashfeld, B.L. Design, synthesis, and evaluation of curcumin-derived arylheptanoids for glioblastoma and neuroblastoma cytotoxicity. Bioorg. Med. Chem. Lett., 2013, 23(24), 6874-6878.
79. [79] Péret-Almeida, L.; Cherubino, A.; Alves, R.; Dufossé, L.; Gloria, M., Separation and determination of the physico-chemical characteristics of curcumin, demethoxycurcumin and bisdemethoxycurcumin. Food Res. Int., 2005, 38(8), 1039-1044.
80. [80] Chignell, C.F.; Bilskj, P.; Reszka, K.J.; Motten, A.G.; Sik, R.H.; Dahl, T.A., Spectral and photochemical properties of curcumin. Photochem. Photobiol., 1994, 59(3), 295-302.
81. [81] Shen, L.; Ji, H.F. The pharmacology of curcumin: is it the degradation products? Trends Mol. Med., 2012, 18(3), 138-144.
82. [82] Priyadarsini, K.I.; Maity, D.K.; Naik, G.; Kumar, M.S.; Unnikrishnan, M.; Satav, J.; Mohan, H. Role of phenolic OH and methylene hydrogen on the free radical reactions and antioxidant activity of curcumin. Free Radic. Biol. Med., 2003, 35(5), 475-484.
83. [83] Payton, F.; Sandusky, P.; Alworth, W.L., NMR study of the solution structure of curcumin. J. Nat. Prod., 2007, 70(2), 143-146.
84. [84] Tønnesen, H.H.; Karlsen, J. Studies on curcumin and curcuminoids. Z. Lebensm. Unters. Forsch., 1985, 180(5), 402-404.
85. [85] Tønnesen, H.H.; Karlsen, J.; van Henegouwen G.B. Studies on curcumin and curcuminoids VIII. Photochemical stability of curcumin. Z. Lebensm. Unters. Forsch., 1986, 183(2), 116-122.
86. [86] Tønnesen, H.H.; Másson, M.; Loftsson, T. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. Int. J. Pharm., 2002, 244(1), 127-135.
87. [87] Li, S.; Yuan, W.; Deng, G.; Wang, P.; Yang, P.; Aggarwal, B. Chemical composition and product quality control of turmeric (Curcuma longa L.). Pharm. Crops, 2011, 2, 28-54
88. [88] Goel, A.; Kunnumakkara, A.B.; Aggarwal, B.B. Curcumin as “Curecumin”: from kitchen to clinic. Biochem. Pharmacol., 2008, 75(4), 787-809.
89. [89] Wang, L.; Weller, C.L. Recent advances in extraction of nutraceuticals from plants. Trends Food Sci. Technol., 2006, 17(6), 300-312.
90. [90] Ignat, I.; Volf, I.; Popa, V.I. A critical review of methods for characterisation of polyphenolic compounds in fruits and vegetables. Food Chem., 2011, 126(4), 1821-1835.
91. [91] Verghese, J. Isolation of curcumin from Curcuma longa L. rhizome. Flav. Fragr. J., 1993, 8(6), 315-319.
92. [92] Euterpio, M.A.; Cavaliere, C.; Capriotti, A.L.; Crescenzi, C. Extending the applicability of pressurized hot water extraction to compounds exhibiting limited water solubility by pH control: curcumin from the turmeric rhizome. Anal. Bioanal. Chem., 2011, 401(9), 2977-2985.
93. [93] Krishnaveni, M. A natural dietary product-curcumin as a potential anticancer agent. Int. J. Nat. Sci., 2012, 1(1), 29-34.
94. [94] Dandekar, D.V.; Gaikar, V. Microwave assisted extraction of curcuminoids from Curcuma longa. Sep. Sci. Technol., 2002, 37(11), 2669-2690.
95. [95] Sachan, K.; Kapoor, V. Optimization of extraction and dyeing conditions for traditional turmeric dye. Indian J. Tradit. Knowl., 2007, 6(2), 270-278.
96. [96] Kewen, T.; Jianmin, Y.; Li, L. Microwave assisted extractionadsorption separation of curcumin from turmeric. Chem. Ind. Eng. Prog., 2005, 24(6), 647.
97. [97] Srinivas, K.; King, J.W. 3 Supercritical carbon dioxide and subcritical water: Complementary agents in the processing of functional foods. Funct. Food Prod. Dev., 2010, 39.
98. [98] Anand, P.; Kunnumakkara, A.B.; Newman, R.A.; Aggarwal, B.B. Bioavailability of curcumin: problems and promises. Mol. Pharm., 2007, 4(6), 807-818.
99. [99] Shoba, G.; Joy, D.; Joseph, T.; Majeed, M.; Rajendran, R.; Srinivas, P. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med., 1998, 64(4), 353-356.
100. [100] Iwunze, M.O. Binding and distribution characteristics of curcumin solubilized in CTAB micelle. J. Mol. Liq., 2004, 111(1), 161-165.
101. [101] Canamares, M.; Garcia-Ramos, J.; Sanchez-Cortes, S. Degradation of curcumin dye in aqueous solution and on Ag nanoparticles studied by ultraviolet–visible absorption and surface-enhanced raman spectroscopy. Appl. Spectrosc., 2006, 60(12), 1386-1391.
102. [102] Singh, S.; Aggarwal, B.B. Activation of transcription factor NF-κB is suppressed by curcumin (diferuloylmethane). J. Biol. Chem., 1995, 270(42), 24995-25000.
103. [103] Shaikh, J.; Ankola, D.; Beniwal, V.; Singh, D.; Kumar, M.R. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur. J. Pharm. Sci., 2009, 37(3), 223-230.
104. [104] Kakkar, V.; Singh, S.; Singla, D.; Kaur, I.P. Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin. Mol. Nutr. Food Res., 2011, 55(3), 495-503.
105. [105] Mohanty, C.; Das, M.; Sahoo, S.K. Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin. Expert Opin. Drug Deliv., 2012, 9(11), 1347-1364.
106. [106] Begum, A.N.; Jones, M.R.; Lim, G.P.; Morihara, T.; Kim, P.; Heath, D.D.; Rock, C.L.; Pruitt, M.A.; Yang, F.; Hudspeth, B. Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. J. Pharmacol. Exp. Ther., 2008, 326(1), 196-208.
107. [107] Chainani-Wu, N. Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J. Altern. Complement. Med., 2003, 9(1), 161-168.
108. [108] Hsu, C.H.; Cheng, A.L. In The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease; Aggarwal, B.B., Surh Y.J., Shishodia, S., Eds; Springer: New York, 2007, pp 471-480.
109. [109] Sharma, R.; Gescher, A.; Steward, W. Curcumin: the story so far. Eur. J.Cancer, 2005, 41(13), 1955-1968.
110. [110] Bisht, S.; Maitra, A. Systemic delivery of curcumin: 21st century solutions for an ancient conundrum. Curr. Drug Discov. Technol., 2009, 6(3), 192-199.
111. [111] Trujillo, J.; Chirino, Y.I.; Molina-Jijón, E.; Andérica-Romero, A.C.; Tapia, E.; Pedraza-Chaverrí, J. Renoprotective effect of the antioxidant curcumin: Recent findings. Redox Biol., 2013, 1(1), 448-456.
112. [112] Esatbeyoglu, T.; Huebbe, P.; Ernst, I.; Chin, D.; Wagner, A.E.; Rimbach, G. Curcumin-from molecule to biological function. Angew. Chem. Int. Ed. Engl., 2012, 51(22), 5308-5332.
113. [113] Wu, J.Y.; Lin, C.-Y.; Lin, T.W.; Ken, C.-F.; Wen, Y.D. Curcumin affects development of zebrafish embryo. Biol. Pharm. Bull., 2007, 30(7), 1336-1339.
114. [114] Aggarwal, B.B.; Sundaram, C.; Malani, N.; Ichikawa, H. In The molecular targets and therapeutic uses of curcumin in health and disease; Aggarwal, B.B., Surh Y.J., Shishodia, S., Eds; Springer: New York, 2007, pp 1-75.
115. [115] Thiyagarajan, S.; Thirumalai, K.; Nirmala, S.; Biswas, J.; Krishnakumar, S. Effect of curcumin on lung resistance-related protein (LRP) in retinoblastoma cells. Curr. Eye Res., 2009, 34(10), 845-851.
116. [116] Rasyid, A.; Rahman, A.R.A.; Jaalam, K.; Lelo, A. Effect of different curcumin dosages on human gall bladder. Asia Pac. J. Clin. Nutr., 2002, 11(4), 314-318.
117. [117] Emoto, Y.; Yoshizawa, K.; Uehara, N.; Kinoshita, Y.; Yuri, T.; Shikata, N.; Tsubura, A. Curcumin suppresses N-methyl-Nnitrosourea-induced photoreceptor apoptosis in Sprague-Dawley rats. In vivo, 2013, 27(5), 583-590.
118. [118] Assad, G.F.; Buraydah, K. Toxicological impact of Amaranth, Sunset Yellow and Curcumin as food coloring agents in albino rats. J. Pak. Med. Students, 2011, 1(2), 43-51.
119. [119] Halder, N.; Joshi, S.; Gupta, S. Lens aldose reductase inhibiting potential of some indigenous plants. J. Ethnopharmacol., 2003, 86(1), 113-116.
120. [120] Suryanarayana, P.; Saraswat, M.; Mrudula, T.; Krishna, T.P.; Krishnaswamy, K.; Reddy, G.B. Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats. Invest. Ophthalmol. Vis. Sci., 2005, 46(6), 2092-2099.
121. [121] Sajithlal, G.; Chithra, P.; Chandrakasan, G. Effect of curcumin on the advanced glycation and cross-linking of collagen in diabetic rats. Biochem. Pharmacol., 1998, 56(12), 1607-1614.
122. [122] Meghana, K.; Sanjeev, G.; Ramesh, B. Curcumin prevents streptozotocin- induced islet damage by scavenging free radicals: a prophylactic and protective role. Eur. J. Pharmacol., 2007, 577(1), 183-191.
123. [123] Stefanska, B. Curcumin ameliorates hepatic fibrosis in type 2 diabetes mellitus–insights into its mechanisms of action. Br. J. Pharmacol., 2012, 166(8), 2209-2211.
124. [124] Jain, S.K.; Rains, J.; Jones, K. Effect of curcumin on protein glycosylation, lipid peroxidation, and oxygen radical generation in human red blood cells exposed to high glucose levels. Free Radic. Biol. Med., 2006, 41(1), 92-96.
125. [125] Pari, L.; Murugan, P., Changes in glycoprotein components in streptozotocin-nicotinamide induced type 2 diabetes: influence of tetrahydrocurcumin from Curcuma longa. Plant Foods Hum. Nutr., 2007, 62(1), 25-29.
126. [126] Pari, L.; Murugan, P., Antihyperlipidemic effect of curcumin and tetrahydrocurcumin in experimental type 2 diabetic rats. Ren. Fail., 2007, 29(7), 881-889.
127. [127] Nishiyama, T.; Mae, T.; Kishida, H.; Tsukagawa, M.; Mimaki, Y.; Kuroda, M.; Sashida, Y.; Takahashi, K.; Kawada, T.; Nakagawa, K. Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice. J. Agric. Food Chem., 2005, 53(4), 959-963.
128. [128] Kuroda, M.; Mimaki, Y.; Nishiyama, T.; Mae, T.; Kishida, H.; Tsukagawa, M.; Takahashi, K.; Kawada, T.; Nakagawa, K.; Kitahara, M. Hypoglycemic effects of turmeric (Curcuma longa L. rhizomes) on genetically diabetic KK-Ay mice. Biol. Pharm. Bull., 2005, 28(5), 937-939.
129. [129] Jiménez-Flores, L.M.; López-Briones, S.; Macías-Cervantes, M.H.; Ramírez-Emiliano, J.; Pérez-Vázquez, V. A PPARγ, NF-κB and AMPK-dependent mechanism may be involved in the beneficial effects of curcumin in the diabetic db/db mice liver. Molecules, 2014, 19(6), 8289-8302.
130. [130] Lin, J.; Chen, A. Curcumin diminishes the impacts of hyperglycemia on the activation of hepatic stellate cells by suppressing membrane translocation and gene expression of glucose transporter-2. Mol. Cell. Endocrinol., 2011, 333(2), 160-171.
131. [131] Rashid, K.; Sil, P.C. Curcumin enhances recovery of pancreatic islets from cellular stress induced inflammation and apoptosis in diabetic rats. Toxicol. Appl. Pharmacol., 2014, 282(3), 297-310
132. [132] Varsha, M.S.; Thiagarajan, R.; Manikandan, R.; Dhanasekaran, G. Vitamin K1 alleviates streptozotocin-induced type 1 diabetes by mitigating free radical stress, as well as inhibiting NF-κB activation and iNOS expression in rat pancreas. Nutrition, 2015, 31(1), 214-222.
133. [133] Arun, N.; Nalini, N. Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats. Plant Foods Hum. Nutr., 2002, 57(1), 41-52.
134. [134] Muthenna, P.; Suryanarayana, P.; Gunda, S.K.; Petrash, J.M.; Reddy, G.B. Inhibition of aldose reductase by dietary antioxidant curcumin: mechanism of inhibition, specificity and significance. FEBS lett., 2009, 583(22), 3637-3642.
135. [135] Kang, E.S.; Kim, H.J.; Eun, S.Y.; Paek, K.S.; Kim, H.J.; Chang, K.C.; Lee, J.H.; Lee, H.T.; Kim, J.H.; Nishinaka, T. Up-regulation of aldose reductase expression mediated by phosphatidylinositol 3- kinase/Akt and Nrf2 is involved in the protective effect of curcumin against oxidative damage. Free Radic. Biol. Med., 2007, 43(4), 535-545.
136. [136] Mahesh, T.; Balasubashini, M.S.; Menon, V.P. Effect of photoirradiated curcumin treatment against oxidative stress in streptozotocin- induced diabetic rats. J. Med. Food, 2005, 8(2), 251-255.
137. [137] El-Bahr, S.M. Curcumin regulates gene expression of insulin like growth factor, B-cell CLL/lymphoma 2 and antioxidant enzymes in streptozotocin induced diabetic rats. BMC Complement. Altern. Med., 2013, 13(1), 368.
138. [138] Jain, S.K.; Rains, J.; Croad, J.; Larson, B.; Jones, K. Curcumin supplementation lowers TNF-α, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF- α, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats. Antioxid. Redox Signal., 2009, 11(2), 241-249.
139. [139] El-Azab, M.F.; Attia, F.M.; El-Mowafy, A.M. Novel role of curcumin combined with bone marrow transplantation in reversing experimental diabetes: Effects on pancreatic islet regeneration, oxidative stress, and inflammatory cytokines. Eur. J. Pharmacol., 2011, 658(1), 41-48.
140. [140] Soto-Urquieta, M.G.; López-Briones, S.; Pérez-Vázquez, V.; Saavedra-Molina, A.; González-Hernández, G. A.; Ramírez-Emiliano, J. Curcumin restores mitochondrial functions and decreases lipid peroxidation in liver and kidneys of diabetic db/db mice. Biol. Res., 2014, 47(1), 74.
141. [141] Rivera-Mancía, S.; Lozada-García, M.C.; Pedraza-Chaverri, J. Experimental evidence for curcumin and its analogs for management of diabetes mellitus and its associated complications. Eur. J. Pharmacol., 2015, 756, 30-37
142. [142] Tsuda, T. Possible abilities of dietary factors to prevent and treat diabetes via the stimulation of glucagon-like peptide-1 secretion. Mol. Nutr. Food Res., 2015, 59(7),1264-1273.
143. [143] Best, L.; Elliott, A.C.; Brown, P.D. Curcumin induces electrical activity in rat pancreatic β-cells by activating the volume-regulated anion channel. Biochem. Pharmacol., 2007, 73(11), 1768-1775.
144. [144] Pugazhenthi, S.; Akhov, L.; Selvaraj, G.; Wang, M.; Alam, J. Regulation of heme oxygenase-1 expression by demethoxy curcuminoids through Nrf2 by a PI3-kinase/Akt-mediated pathway in mouse β-cells. Am. J. Physiol. Endocrinol. Metab., 2007, 293(3), E645-E655.
145. [145] Balamurugan, A.; Akhov, L.; Selvaraj, G.; Pugazhenthi, S. Induction of antioxidant enzymes by curcumin and its analogues in human islets: implications in transplantation. Pancreas, 2009, 38(4), 454-460.
146. [146] Fujiwara, H.; Hosokawa, M.; Zhou, X.; Fujimoto, S.; Fukuda, K.; Toyoda, K.; Nishi, Y.; Fujita, Y.; Yamada, K.; Yamada, Y. Curcumin inhibits glucose production in isolated mice hepatocytes. Diabetes Res. Clin. Pract., 2008, 80(2), 185-191.
147. [147] Kim, T.; Davis, J.; Zhang, A.J.; He, X.; Mathews, S.T. Curcumin activates AMPK and suppresses gluconeogenic gene expression in hepatoma cells. Biochem. Biophys. Res. Commun., 2009, 388(2), 377-382.
148. [148] Xavier, S.; Sadanandan, J.; George, N.; Paulose, C.S. β 2- adrenoceptor and insulin receptor expression in the skeletal muscle of streptozotocin induced diabetic rats: antagonism by vitamin D 3 and curcumin. Eur. J. Pharmacol., 2012, 687(1), 14-20.
149. [149] Cheng, T.C.; Lin, C.S.; Hsu, C.C.; Chen, L.-J.; Cheng, K.C.; Cheng, J.T. Activation of muscarinic M-1 cholinoceptors by curcumin to increase glucose uptake into skeletal muscle isolated from Wistar rats. Neurosci. Lett., 2009, 465(3), 238-241.
150. [150] Na, L.X.; Zhang, Y.L.; Li, Y.; Liu, L.Y.; Li, R.; Kong, T.; Sun, C.H. Curcumin improves insulin resistance in skeletal muscle of rats. Nutr. Metab. Cardiovasc. Dis., 2011, 21(7), 526-533.
151. [151] Lin, J.; Zheng, S.; Chen, A. Curcumin attenuates the effects of insulin on stimulating hepatic stellate cell activation by interrupting insulin signaling and attenuating oxidative stress. Lab. Invest., 2009, 89(12), 1397-1409.
152. [152] Ponnusamy, S.; Zinjarde, S.; Bhargava, S.; Rajamohanan, P.; RaviKumar, A. Discovering Bisdemethoxycurcumin from Curcuma longa rhizome as a potent small molecule inhibitor of human pancreatic α-amylase, a target for type-2 diabetes. Food Chem., 2012, 135(4), 2638-2642.
153. [153] Yun, J.M.; Jialal, I.; Devaraj, S. Epigenetic regulation of high glucose- induced proinflammatory cytokine production in monocytes by curcumin. J. Nutr. Biochem., 2011, 22(5), 450-458.
154. [154] Dang, T.T.; Thai, A.V.; Cohen, J.; Slosberg, J.E.; Siniakowicz, K.; Doloff, J.C.; Ma, M.; Hollister-Lock, J.; Tang, K.M.; Gu, Z. Enhanced function of immuno-isolated islets in diabetes therapy by co-encapsulation with an anti-inflammatory drug. Biomaterials, 2013, 34(23), 5792-5801.
155. [155] Castro, C.N.; Barcala Tabarrozzi, A.; Winnewisser, J.; Gimeno, M.L.; Antunica Noguerol, M.; Liberman, A.C.; Paz, D.A.; Dewey, R.A.; Perone, M.J. Curcumin ameliorates autoimmune diabetes. Evidence in accelerated murine models of type 1 diabetes. Clin. Exp. Immunol., 2014, 177(1), 149-160.
156. [156] Aziz, M.T.A.; El-Asmar, M.F.; Rezq, A.M.; Mahfouz, S.M.; Wassef, M.A.; Fouad, H.H.; Ahmed, H.H.; Taha, F.M. The effect of a novel curcumin derivative on pancreatic islet regeneration in experimental type-1 diabetes in rats (long term study). Diabetol. Metab. Syndr., 2013, 5(1), 75.
157. [157] Arivazhagan, A.; Krishna, S.; Yadav, S.; Shah, H.R.; Kumar, P.; Ambasta, R.K. Synergy of bone marrow transplantation and curcumin ensue protective effects at early onset of diabetes in mice. J. Diabetes, 2014, 7(4), 473-484.
158. [158] Daval, M.; Bedrood, S.; Gurlo, T.; Huang, C.J.; Costes, S.; Butler, P.C.; Langen, R. The effect of curcumin on human islet amyloid polypeptide misfolding and toxicity. Amyloid, 2010, 17(3-4), 118-128.
159. [159] Sparks, S.; Liu, G.; Robbins, K.J.; Lazo, N.D. Curcumin modulates the self-assembly of the islet amyloid polypeptide by disassembling α-helix. Biochem. Biophys. Res. Commun., 2012, 422(4), 551-555.
160. [160] Murugan, P.; Pari, L.; Rao, C.A. Effect of tetrahydrocurcumin on insulin receptor status in type 2 diabetic rats: studies on insulin binding to erythrocytes. J. Biosci., 2008, 33(1), 63-72.
161. [161] Seo, K.I.; Choi, M.S.; Jung, U.J.; Kim, H.J.; Yeo, J.; Jeon, S.M.; Lee, M.K. Effect of curcumin supplementation on blood glucose, plasma insulin, and glucose homeostasis related enzyme activities in diabetic db/db mice. Mol. Nutr. Food Res., 2008, 52(9), 995-1004.
162. [162] Rouse, M.; Younès, A.; Egan, J.M. Resveratrol and curcumin enhance pancreatic β-cell function by inhibiting phosphodiesterase activity. J. Endocrinol., 2014, 223(2), 107-117.
163. [163] Majithiya, J.B.; Balaraman, R.; Giridhar, R.; Yadav, M.R. Effect of bis [curcumino] oxovanadium complex on non-diabetic and streptozotocin- induced diabetic rats. J. Trace Elem. Med. Biol., 2005, 18(3), 211-217.
164. [164] Mohammadi, K.; Thompson, K.H.; Patrick, B.O.; Storr, T.; Martins, C.; Polishchuk, E.; Yuen, V.G.; McNeill, J.H.; Orvig, C. Synthesis and characterization of dual function vanadyl, gallium and indium curcumin complexes for medicinal applications. J. Inorg. Biochem., 2005, 99(11), 2217-2225.
165. [165] Steigerwalt, R.; Nebbioso, M.; Appendino, G.; Belcaro, G.; Ciammaichella, G.; Cornelli, U.; Luzzi, R.; Togni, S.; Dugall, M.; Cesarone, M. Meriva®, a lecithinized curcumin delivery system, in diabetic microangiopathy and retinopathy. Panminerva Med., 2012, 54(4), 11-16.
166. [166] Na, L.X.; Li, Y.; Pan, H.Z.; Zhou, X.L.; Sun, D.J.; Meng, M.; Li, X.X.; Sun, C.H. Curcuminoids exert glucose_lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double _blind, placebo-controlled trial. Mol. Nutr. Food Res., 2013, 57(9), 1569-1577.
167. [167] Appendino, G.; Belcaro, G.; Cornelli, U.; Luzzi, R.; Togni, S.; Dugall, M.; Cesarone, M.; Feragalli, B.; Ippolito, E.; Errichi, B. Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study. Panminerva Med., 2011, 53(3 Suppl 1), 43-49.
168. [168] Khajehdehi, P.; Pakfetrat, M.; Javidnia, K.; Azad, F.; Malekmakan, L.; Nasab, M.H.; Dehghanzadeh, G. Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin- 8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study. Scand. J. Urol. Nephrol., 2011, 45(5), 365-370.
169. [169] Usharani, P.; Mateen, A.; Naidu, M.; Raju, Y.; Chandra, N. Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus. Drugs R. D., 2008, 9(4), 243-250.